LeonaBio (LONA) EBT (2019 - 2026)
LeonaBio's (LONA) quarterly EBT came in at -$21.1 million in Q1 2026, down 96.12% year-on-year from -$543.5 million in Q1 2025, and up 73.81% on a QoQ basis from -$80.6 million in Q4 2025.
LeonaBio (LONA) EBT (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of EBT data on file, last reported at -$21.1 million in Q1 2026.
- On a quarterly basis, EBT fell 96.12% year-over-year to -$21.1 million in Q1 2026; TTM through Mar 2026 was -$118.0 million, a 33.75% increase from a year earlier, with the FY2025 full-year figure at -$105.6 million, down 8.98% from the prior year.
- EBT for Q1 2026 stood at -$21.1 million, up from -$80.6 million in the prior quarter.
- Over the last five years, EBT for LONA reached as high as -$7.9 million in Q3 2025 and fell as low as -$107.5 million in Q4 2024.
- Historically, EBT has averaged -$33.8 million across 5 years, with a median of -$29.4 million in 2023.
- Across the five-year window, EBT slumped 265.68% in 2024 and soared 74.74% in 2025, its largest moves.
- Year by year, EBT stood at -$33.3 million in 2022, then rose by 11.77% to -$29.4 million in 2023, then slumped by 265.68% to -$107.5 million in 2024, then increased by 25.04% to -$80.6 million in 2025, then soared by 73.81% to -$21.1 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$21.1 million in Q1 2026, -$80.6 million in Q4 2025, and -$7.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | -21.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.11 Mn |
| Dec 31, 2025 | -80.60 Mn |
| Sep 30, 2025 | -7.86 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Mar 31, 2025 | -10.76 Mn |
| Dec 31, 2024 | -107.52 Mn |
| Sep 30, 2024 | -31.09 Mn |
| Jun 30, 2024 | -28.68 Mn |
| Mar 31, 2024 | -29.40 Mn |
| Dec 31, 2023 | -29.40 Mn |
| Sep 30, 2023 | -36.99 Mn |
| Jun 30, 2023 | -33.71 Mn |
| Mar 31, 2023 | -31.95 Mn |
| Dec 31, 2022 | -33.32 Mn |
| Sep 30, 2022 | -26.54 Mn |
| Jun 30, 2022 | -24.36 Mn |
| Mar 31, 2022 | -33.52 Mn |
| Dec 31, 2021 | -18.78 Mn |
| Sep 30, 2021 | -23.83 Mn |
| Jun 30, 2021 | -24.34 Mn |